This inhibitory role may facilitate Htatip2 as a tumor repressor since down-regulation of Htatip2 is associated with development of a number of cancer and/or induction of aggressive metastasis, including lung cancer [31], hepatocarcinoma [32, 33], breast cancer [34], brain tumor [35]. The gene discussed is HTATIP2; the disease is breast carcinoma.